Ardelyx, Inc. (ARDX)
3.735
-0.16
(-3.98%)
USD |
NASDAQ |
Aug 24, 16:00
3.76
+0.02
(+0.67%)
After-Hours: 20:00
Ardelyx Debt to Equity Ratio : 1.719 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.719 |
| March 31, 2026 | 1.401 |
| December 31, 2025 | 1.246 |
| September 30, 2025 | 1.346 |
| June 30, 2025 | 1.481 |
| March 31, 2025 | 1.065 |
| December 31, 2024 | 0.8854 |
| September 30, 2024 | 0.6601 |
| June 30, 2024 | 0.7136 |
| March 31, 2024 | 0.6954 |
| December 31, 2023 | 0.3356 |
| September 30, 2023 | 0.1801 |
| June 30, 2023 | 0.2834 |
| March 31, 2023 | 0.2846 |
| December 31, 2022 | 0.4852 |
| September 30, 2022 | 0.5565 |
| June 30, 2022 | 0.7149 |
| March 31, 2022 | 0.6005 |
| December 31, 2021 | 0.5508 |
| September 30, 2021 | 0.8048 |
| June 30, 2021 | 0.5612 |
| March 31, 2021 | 0.4038 |
| December 31, 2020 | 0.4228 |
| September 30, 2020 | 0.407 |
| June 30, 2020 | 0.3682 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.3237 |
| December 31, 2019 | 0.293 |
| September 30, 2019 | 1.120 |
| June 30, 2019 | 0.8066 |
| March 31, 2019 | 0.6051 |
| December 31, 2018 | 0.4249 |
| September 30, 2018 | 0.3466 |
| June 30, 2018 | 0.2988 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| REGENXBIO, Inc. | 3.49 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 575.89M |
| Total Liabilities (Quarterly) | 426.88M |
| Shareholders Equity (Quarterly) | 149.01M |
| Current Ratio | 3.342 |
| Net Debt Paydown Yield | -1.59% |